Literature DB >> 1963847

Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.

M J Owens1, E Edwards, C B Nemeroff.   

Abstract

Corticotropin-releasing factor (CRF) is the major physiological regulator of the hypothalamo-pituitary-adrenal axis. There is evidence that CRF release from the hypothalamus is under stimulatory serotonergic control. The specific 5-HT receptor subtypes that mediate this effect is unclear. Administration of the 5-HT1A agonists, 8-OH-DPAT (1 mg/kg) and ipsapirone (4 mg/kg), to rats resulted in activation of the HPA axis as evidenced by increased plasma ACTH and corticosterone concentrations in acutely treated rats and increased plasma corticosterone concentrations in both acutely and chronically treated rats. However, chronic administration of these compounds failed to alter CRF concentrations in the medium eminence or CRF receptor number of affinity in the anterior pituitary. Chronic administration of both compounds resulted in increased CRF concentrations in the piriform cortex and hippocampus, whereas 8-OH-DPAT alone increased CRF concentrations in the amygdala and entorhinal cortex. These results suggest that both hypothalamic and extrahypothalamic CRF neurons are influenced by activation of 5-HT1A receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963847     DOI: 10.1016/0014-2999(90)94118-h

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats.

Authors:  C L Ehlers; R I Chaplin; T L Wall; L Lumeng; T K Li; M J Owens; C B Nemeroff
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.

Authors:  N Laflamme; S Bovetto; D Richard; S Rivest
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake.

Authors:  Michel M M Verheij; Candice Contet; Peter Karel; Judith Latour; Rick H A van der Doelen; Bram Geenen; Josephus A van Hulten; Francisca Meyer; Tamas Kozicz; Olivier George; George F Koob; Judith R Homberg
Journal:  Biol Psychiatry       Date:  2017-11-20       Impact factor: 13.382

4.  The antagonism of ipsapirone induced biobehavioral responses by +/- pindolol in high and low impulsives.

Authors:  J Hennig; C Opper; S Huwe; P Netter
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 5.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

6.  Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

Authors:  H. M. Van Praag
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

7.  Effects of ipsapirone in healthy subjects: a dose-response study.

Authors:  R S Kahn; R Trestman; B A Lawlor; S Gabriel; M Davidson; L Siever
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

8.  Stress: Neurobiology, consequences and management.

Authors:  Anil Kumar; Puneet Rinwa; Gurleen Kaur; Lalit Machawal
Journal:  J Pharm Bioallied Sci       Date:  2013-04

9.  Evaluation of sesamol and buspirone in stress induced anxiety in mice.

Authors:  Anil Kumar; Gurleen Kaur; Harikesh Kalonia; Puneet Rinwa
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.